HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$17.60
Day range
$17.08 - $17.72
Year range
$14.15 - $29.30
Market cap
2.87B USD
Avg Volume
3.25M
P/E ratio
22.26
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 250.40M | 18.28% |
Operating expense | 118.39M | 20.95% |
Net income | 32.76M | 150.27% |
Net profit margin | 13.09 | 142.51% |
Earnings per share | 0.20 | 150.00% |
EBITDA | 49.11M | 187.62% |
Effective tax rate | 15.57% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 565.33M | 63.43% |
Total assets | 976.87M | 54.44% |
Total liabilities | 399.69M | 47.83% |
Total equity | 577.18M | — |
Shares outstanding | 166.39M | — |
Price to book | 5.07 | — |
Return on assets | 12.31% | — |
Return on capital | 19.38% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 32.76M | 150.27% |
Cash from operations | 63.25M | 207.28% |
Cash from investing | -82.46M | -341.74% |
Cash from financing | 268.00K | -97.90% |
Net change in cash | -18.98M | -56.93% |
Free cash flow | 70.39M | 333.00% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
620
